Mannatech (NASDAQ:MTEX) Director Acquires 2,803 Shares

Mannatech, Incorporated (NASDAQ:MTEXGet Free Report) Director Larry Jobe bought 2,803 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The shares were bought at an average price of $4.12 per share, for a total transaction of $11,548.36. Following the completion of the acquisition, the director owned 70,000 shares in the company, valued at approximately $288,400. This trade represents a 4.17% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Mannatech Stock Up 10.4%

NASDAQ MTEX traded up $0.41 on Thursday, reaching $4.36. The company had a trading volume of 208,929 shares, compared to its average volume of 26,830. The firm has a market capitalization of $8.41 million, a PE ratio of -0.65 and a beta of 0.61. Mannatech, Incorporated has a 1 year low of $3.80 and a 1 year high of $12.45. The firm has a 50-day moving average of $5.56 and a 200-day moving average of $7.28. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.09 and a quick ratio of 0.59.

Mannatech (NASDAQ:MTEXGet Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.49 earnings per share (EPS) for the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%. The company had revenue of $24.92 million for the quarter.

About Mannatech

(Get Free Report)

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.

Recommended Stories

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.